Abbott Laboratories and Nevro are back before the U.S. Judicial Panel on Multidistrict Litigation this week to argue why lawsuits over their spinal cord stimulators shouldn’t be coordinated.
Abbott Laboratories and Nevro are back before the U.S. Judicial Panel on Multidistrict Litigation this week to argue why lawsuits over their spinal cord stimulators shouldn’t be coordinated.

